Literature DB >> 3319231

Modification of human serum low density lipoprotein by oxidation--characterization and pathophysiological implications.

G Jürgens1, H F Hoff, G M Chisolm, H Esterbauer.   

Abstract

Plasma low density lipoprotein (LDL) can undergo free radical oxidation either catalyzed by divalent cations, such as Cu2+ or Fe2+ or promoted by incubation with cultured cells such as endothelial cells, smooth muscle cells and monocytes. The content of vitamin E, beta-carotene and unsaturated fatty acids is decreased in oxidized LDL. A breakdown of apolipoprotein-B (apoB), hydrolysis of the phospholipids, an increase of thiobarbituric acid reactive substances and the generation of aldehydes also occur. Changes in the ratio of lipid to protein, the electrophoretic mobility and the fluorescent properties have also been reported to accompany oxidation of this lipoprotein. The functional changes of oxidized LDL include its recognition by the scavenger receptor on macrophages, its cytotoxicity especially to proliferating cells, its chemotactic properties with respect to monocyte-macrophages and its regulation of platelet-derived growth factor-like protein (PDGFc) production by endothelial cells. In this article we summarize some of the contributions to this topic and present speculations relating oxidized LDL to pathological conditions such as atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3319231     DOI: 10.1016/0009-3084(87)90070-3

Source DB:  PubMed          Journal:  Chem Phys Lipids        ISSN: 0009-3084            Impact factor:   3.329


  45 in total

1.  Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and nonreciprocal cross competition by acetylated and oxidized low density lipoprotein.

Authors:  M Freeman; Y Ekkel; L Rohrer; M Penman; N J Freedman; G M Chisolm; M Krieger
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-01       Impact factor: 11.205

2.  Interactions of serum copper, selenium, and low density lipoprotein cholesterol in atherogenesis.

Authors:  J T Salonen; R Salonen; K Seppänen; M Kantola; S Suntioinen; H Korpela
Journal:  BMJ       Date:  1991-03-30

3.  Quantitative determination of low density lipoprotein oxidation by FTIR and chemometric analysis.

Authors:  Henry S Lam; Andrew Proctor; John Nyalala; Manford D Morris; W Grady Smith
Journal:  Lipids       Date:  2004-07       Impact factor: 1.880

Review 4.  Role of oxidized low density lipoprotein in atherogenesis.

Authors:  J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

Review 5.  Nutrient supplements and cardiovascular disease: a heartbreaking story.

Authors:  Alice H Lichtenstein
Journal:  J Lipid Res       Date:  2008-11-06       Impact factor: 5.922

6.  A serum factor that suppresses the cytotoxic function of cytokine-stimulated human eosinophils.

Authors:  D S Silberstein; M S Minkoff; A A Creasey; J R David
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

Review 7.  Free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis.

Authors:  B Halliwell
Journal:  Br J Exp Pathol       Date:  1989-12

8.  The action of defined oxygen-centred free radicals on human low-density lipoprotein.

Authors:  S Bedwell; R T Dean; W Jessup
Journal:  Biochem J       Date:  1989-09-15       Impact factor: 3.857

9.  Charge-derivatized amino acids facilitate model studies on protein side-chain modifications by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry.

Authors:  Xiaochun Zhu; Vernon E Anderson; Lawrence M Sayre
Journal:  Rapid Commun Mass Spectrom       Date:  2009-07       Impact factor: 2.419

10.  Transfer of phosphatidylcholine, phosphatidylethanolamine and sphingomyelin from low- and high-density lipoprotein to human platelets.

Authors:  B Engelmann; C Kögl; R Kulschar; B Schaipp
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.